ArticleJAMA network open2025
Maternal Vulnerability Index and Severe Maternal Morbidity.
Article in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Importance: Few studies have investigated the association of composite measures of neighborhood social determinants of health with severe maternal morbidity (SMM), and no research has examined this association for indices tailored to maternal health. Objective: To examine the association of scores in the Maternal Vulnerability Index (MVI), a tool developed to measure maternal risk of adverse health outcomes, with SMM. Design, Setting, and Participants: This retrospective, population-based cohort study was conducted in 5 states (2008-2020 for Michigan, Oregon, and South Carolina; 2008-2018 for Pennsylvania; and 2008-2012 for California) among individuals delivering a fetal death or a live birth between 22 and 44 weeks. Analysis was conducted between August and October 2024. Exposure: The MVI, a composite measure of 43 area-level indicators, was categorized into 6 themes encompassing physical, social, and health care environments. MVI score and themes were examined in quartiles (quartile 1 = lowest risk to quartile 4 = highest risk) based on residential zip code tabulation area. Main Outcomes and Measures: SMM during delivery hospitalization and after discharge within 42 days after delivery. Results: Among 6 543 255 birthing individuals (3 568 631 ages 25-34 years [54.5%]; 472 145 Asian or Pacific Islander [7.2%], 824 239 Black [12.6%], 1 673 917 Hispanic [25.6%], and 3 346 807 White [51.2%]), there were 1 087 936 individuals in MVI quartile 1 (16.6%) and 1 376 658 individuals in MVI quartile 4 (21.0%). A total of 45 051 individuals (0.7%) had SMM during delivery hospitalization, while 13 534 individuals (0.2%) had SMM after discharge within 42 days after delivery. In adjusted analyses, there were no associations between MVI score or themes and SMM during delivery hospitalization. However, a dose-response association was observed between MVI score and SMM within 42 days after delivery (second MVI quartile: adjusted relative risk [aRR], 1.03; 95% CI, 0.95-1.11; third MVI quartile: aRR, 1.12; 95% CI, 1.03-1.23; fourth MVI quartile: aRR, 1.27; 95% CI, 1.14-1.41). The highest MVI quartile in themes of general health care (aRR, 1.27; 95% CI, 1.14-1.43), physical environment (aRR, 1.33; 95% CI, 1.22-1.46), physical health (aRR, 1.23; 95% CI, 1.12-1.35), reproductive health care (aRR, 1.30; 95% CI, 1.15-1.47), and socioeconomic determinants (aRR, 1.19; 95% CI, 1.02-1.39) was associated with SMM within 42 days after delivery. A dose-response association was observed between all MVI themes and SMM within 42 days after delivery (eg, physical environment MVI theme second quartile: aRR, 1.04; 95% CI, 0.96-1.13; third quartile: aRR, 1.14; 95% CI, 1.05-1.25; fourth quartile: aRR, 1.33; 95% CI, 1.22-1.46), except for the mental health and general health care themes. Conclusions and Relevance: In this study, MVI score was not associated with SMM during delivery but was associated with postpartum SMM, suggesting that MVI may capture long-term risks more effectively than acute conditions during delivery hospitalization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.